The Importance of Biomarker Testing for the Effective Treatment of GIST Patients – LRG Science

This issue of LRG Science presents six case studies as evidence that the practice of biomarker/mutational testing early in a GIST patient's journey is a critical path to the most effective treatment. Each patient was diagnosed with GIST, but did not receive mutational testing early enough to avoid suffering adverse side effects and wasting money on unnecessary, costly drugs.

By |2021-09-27T07:30:29-04:00August 30th, 2021|LRG Science, Mutational Testing, News|

‘It’s Time’ to Continue Our Message About Biomarker Testing!

So far in 2021, our 'It's Time' campaign has emphasized twelve important points concerning biomarker testing and the important role it plays in a GIST patient's journey. We will keep the momentum going with patient stories, webinars, and resource materials.

By |2021-09-27T14:30:56-04:00July 22nd, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – It’s Time to Save Lives!

Biomarker testing is an opportunity to improve and optimize treatment. In this post, GISTer Bill Borwegen shares his story and we share how you can help save lives.

By |2021-09-27T14:32:40-04:00July 1st, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – Identify Subsets & Clinical Trials

Identifying rare subsets of GIST and starting new clinical trials is critical. Read here about one researcher's clinical trial progress.

By |2021-09-27T14:37:39-04:00June 25th, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – Standard of Care

If you know your mutation, you have a better chance of getting the most effective treatment more quickly, and increasing your survival time. Making biomarker testing a standard of care will ensure that patients & medical professionals are fully informed so that treatment will be more effective.

By |2021-09-27T14:42:29-04:00June 17th, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – Advocate for this Lifesaving Tool

Uncovering the driving force behind each individual’s tumors is not just important, it is critical. In this post, we feature sarcoma experts discussing biomarker testing.

By |2021-09-27T14:46:46-04:00June 11th, 2021|Mutational Testing, News|

New Horizons GIST Presents Webinar on Mutational Testing for Global Community

This New Horizons GIST webinar is for GIST patients around the world. Hosted by SPAEN, this presentation focuses on mutational testing as a guide for the right therapy.

By |2021-06-10T15:31:15-04:00June 10th, 2021|Advocacy, Global, Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – Educating & Informing Payers

It's Time! Biomarker testing leads to an accurate diagnosis, avoiding the expense of unnecessary, expensive treatments. Biomarker testing leads to an accurate diagnosis, avoiding the expense of unnecessary, expensive treatments.

By |2021-09-27T14:48:40-04:00June 3rd, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – Educating Oncologists

It's #TimeToGetTested. Understanding the role of mutations and biomarker testing is one of most important things patients must learn. It's time to bring together educates physician's about the importance of biomarker testing.

By |2021-09-27T14:49:52-04:00June 1st, 2021|Mutational Testing, News|

It’s Time: The Life Raft Group Biomarker Testing Campaign – The Physician Community Speaks

It's #TimeToGetTested. Understanding the role of mutations and biomarker testing is one of most important things patients must learn. It's time to bring together our physician community to raise their voices! In this post, we present out Biomarker Declaration for GIST pertaining to testing.

By |2021-09-27T14:51:43-04:00May 21st, 2021|Mutational Testing, News|
Go to Top